- Home
- SRPT vs IPAR Comparison
SRPT vs IPAR Comparison
Compare SRPT & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | IPAR |
|---|---|---|
| Founded | 1980 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2000 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SRPT | IPAR |
|---|---|---|
| Price | $22.77 | $90.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 28 | 5 |
| Target Price | $25.40 | ★ $116.60 |
| AVG Volume (30 Days) | ★ 3.2M | 208.3K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ 2.34 |
| EPS | N/A | ★ 5.24 |
| Revenue | ★ $2,198,237,000.00 | $1,317,700,000.00 |
| Revenue This Year | N/A | $4.33 |
| Revenue Next Year | N/A | $8.05 |
| P/E Ratio | ★ N/A | $17.30 |
| Revenue Growth | 15.58 | ★ 21.26 |
| 52 Week Low | $10.42 | $77.21 |
| 52 Week High | $64.80 | $142.50 |
Technical Indicators
Market Signals| Indicator | SRPT | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 64.87 | 42.98 |
| Support Level | $20.61 | $87.33 |
| Resistance Level | $23.51 | $100.43 |
| Average True Range (ATR) | 1.30 | 2.74 |
| MACD | 0.59 | 0.25 |
| Stochastic Oscillator | 85.75 | 49.25 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.